@HTAFAC

Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. A broad level of general and specific recommendations. Great team work @ISHBP @saha_hipertens

1 día de la Escuela de Verano de la Sociedad Argentina de HTA y European Society of Hypertension. Cordoba, Argentina @saha_hipertens @ESHypertension

Improving #atherosclerosis risk prediction #IMPROVE analysis of demographics, molecular markers & clinical assessment generates atherosclerosis endotypes for #PrecisionMedicine bit.ly/3qR3HhU @CVR_TomaszGuzik @DrMikeDrozd @glenpyle #AI #CardiovascularResearch

Proud of this paper as part of the management team of the Global Cardiovascular Risk consortium presented at #ESC2023 @georgeinstitute @UNSWMedicine - showing again that raised #bloodpressure to be the leading contributor to CV outcomes.

"Simposio Cuyano de cardiometabolismo y Riesgo Cardiovascular" 🗓 29 y 30 de Septiembre 📍Merlo, San Luis ➕ Para más información: fac.org.ar/simposio-cuyan… #Simposio #Cardiologia #FAC

Early initiation of the sodium glucose co-transporter 2 (#SGLT2) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in hospitalised patients with acute decompensated heart failure (ADHF). #ESCCongress DICTATE-AHF trial - Early dapagliflozin initiation in acute heart failure.

Very interesting paper by @DaichiShimbo @Kazuomi_Kario and team - 3 days of home #bloodpressure are needed to id high BP. Use of Different BP Thresholds to Reduce the Number of Home BP Monitoring Days Needed for Detecting Hypertension ahajournals.org/doi/10.1161/HY…

Simposio Internacio al de la Sociedad de Cardiologia de Rosario. Un encuentro de gran nivel !!!

Anti-hypertensive medication adherence in the REQUIRE trial: post-hoc exploratory evaluation | Hypertension Research nature.com/articles/s4144…

Muchas gracias Sociedad de Cardiología de Rosario por invitarme a participar del "Simposio Internacional SCR 2023 Investigación, Integración y Desarrollo". Felicitaciones Dr. Luis Keller, Comisión Directiva y secretarias, han puesto la vara muy muy alta!!!

Agradezco mucho la invitación a la Sociedad de Cardiología de Rosario a esta excelente actividad rodeado de amigos y ciencia.

🎥 Watch: ISH President Prof Bryan Williams appears on the @escardio ESC TV in a segment on tough problems in the treatment of #hypertension. Watch the interview (from 5min 39sec): lnkd.in/g_9q-hbh

[REVISTA] Ya está disponible el Suplemento Nro. 3 de la Revista de FAC : “ANTAGONISTAS MINERALOCORTICOIDEOS EN EL CONTINUO CARDIO –NEFRO – METABÓLICO :ROL EMERGENTE DE LA FINERENONA “ ➕ Para más información: revistafac.org.ar/ojs/index.php/… #Revista #FAC

Antagonistas mineralocorticoideos en el continuo cardio-nefro-metabólico, nueva publicación de la Revista de la Federación Argentina de Cardiología. Disponible en revistafac.org.ar/.../revistafac…

Less than 1 month to go until #ESCCongress! Register by 23:59 CEST 31 July to save ⏰ 💸 bit.ly/44S5uSp Join forces w/ thousands of your peers, experience ground-breaking research delivered by trailblazers, & network with the global community to accelerate your career

Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ - PubMed pubmed.ncbi.nlm.nih.gov/37329432/

🔴 Les compartimos la Guía Práctica para el Manejo de la Hipertensión Arterial en las Farmacias 👇 Link💻: saha.org.ar/Guia-Hipertens… #SAHA #HipertensiónArterial

Roche enters partnership with Alnylam for hypertension therapy reuters.com/business/healt…

@DrWanpen presenting at what the future holds for HTN #ASPC2023 🫀 BP control poor during pandemic 🫀multiple causes for this 🫀role of #MRA (@AndrewJSauer 💜) 🫀newer drugs being studied: aprocitentan is phase 3 currently (PRECISION trial) 🫀siRNA technology or vaccine 💉 new

Angiotensinogen plays a key role in hypertension pathogenesis. Zilebesiran, an RNA interference therapeutic agent that inhibits angiotensinogen production, is being studied for hypertension treatment. New research findings are summarized in a short video. nej.md/3rqABWA